Subscribe Sign In Register

Adage

Portfolio
The Morning Brief: Hedge Funds Rocked by Rite-Aid Crash
Firms including Adage, Highfields, and Greenlight are among the drugstore chain’s largest shareholders.
Stephen Taub
June 30, 2017
Portfolio
The Morning Brief: Marcato Claims Victory in Proxy Fight
The San Francisco activist said preliminary tallies show that shareholders of Buffalo Wild Wings elected three of Marcato’s four nominees to the board.
Stephen Taub
June 5, 2017
Portfolio
The Morning Brief: Bridgewater’s Pure Alpha Funds Down in April
The hedge fund firm simultaneously posted gains in its risk parity funds during the month.
Stephen Taub
May 4, 2017
Portfolio
The Morning Brief: Surging Third Point Grows More Bullish
Dan Loeb is cranking up his fund’s gross and net exposures to coincide with his increasingly sunny outlook on the post-Trump markets.
Stephen Taub
April 5, 2017
Portfolio
The Morning Brief: More Redemptions Hit Och-Ziff
The hedge fund firm’s asset drain continues, with investors pulling close to $2 billion over the past month.
Stephen Taub
April 4, 2017
Portfolio
The Morning Brief: Sandell Cuts Stake in Bob Evans Farms
The activist manager is reducing its stake in the company following a victory in its campaign.
Stephen Taub
April 3, 2017
Portfolio
The Morning Brief: Ackman Concedes Valeant “Was a Huge Mistake”
The Pershing Square founder tells investors in his publicly traded vehicle that the Valeant holding accounted for most of its losses last year.
Stephen Taub
March 30, 2017
Portfolio
The Morning Brief: Hedge Fund Favorite Hertz Veers Off the Road
The rental car company’s shares fell on a report that used car pricing is weakening.
Stephen Taub
March 23, 2017
Portfolio
The Morning Brief: Hedge Funds Gain Seats on Two Boards
Alliance Data Systems and Tailored Brands are adding board members from hedge funds that invest in them.
Stephen Taub
March 21, 2017
Portfolio
The Morning Brief: Pershing Square’s Ackman Dumps Valeant Stake
The Pershing Square founder sells off his entire position in the embattled drug maker.
Stephen Taub
March 14, 2017
Load More